RxDoctor Payments Data

Nova Szoka, MD

Obesity Medicine · Morgantown, WVNPI 1912227083

Payments from drug & device makers

$1,307,775in general payments, 2019–2025

Across 37 payments — averaging $35,345 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endolumik, Inc.$1.3M
  • Johnson & Johnson$788
  • Intuitive Surgical$231
  • Davol Inc.$155
  • Reshape Lifesciences Inc.$121
  • Medtronic$104
  • plus $41 from 1 others

What the payments were for

  • Consulting fees$4007%
  • Travel & lodging$4,03170%
  • Food & beverage$1,29422%
  • Entertainment$501%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Endolumik, Inc.15$1,306,334
Johnson & Johnson(2 entities)10$788
Intuitive Surgical8$231
Davol Inc.1$155
Reshape Lifesciences Inc.1$121
Medtronic1$104
Baxter Healthcare1$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few obesity medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$30,236
Medicare patients
54
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate26$2,221
Pantoprazole Sodium44$617
Ondansetron OdtOndansetron15$169
Omeprazole11$101
Oxycodone Hcl19$38

Paid to pharmacies, not to this prescriber.

Other obesity medicine in Morgantown

Where these figures come from

Is this you, or does something look wrong? →